@article{ref1,
title="Corrigendum: adding suicide prevention to the triple advantages of injectable long-acting second-generation antipsychotics",
journal="Frontiers in psychiatry",
year="2020",
author="Pompili, Maurizio",
volume="11",
number="",
pages="e101-e101",
abstract="[This corrects the article DOI: 10.3389/fpsyt.2019.00931.].<br><br>Copyright © 2020 Pompili.  A Corrigendum on Adding Suicide Prevention to the Triple Advantages of Injectable Long-Acting Second-Generation Antipsychotics  By Pompili M. Front. Psychiatry 10:931. doi: 10.3389/fpsyt.2019.00931  The author wishes to disclose that in the last two years he has lectured and served on advisory board honoraria or engaged in clinical trial activities with Angelini, Lundbeck, Janssen, Otsuka, and Allergan.  The author apologizes for this error and states that this does not change the scientific conclusions of the article in any way. The original article has been updated. <p /> <p>Language: en</p>",
language="en",
issn="1664-0640",
doi="10.3389/fpsyt.2020.00101",
url="http://dx.doi.org/10.3389/fpsyt.2020.00101"
}